Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 58
Filtrar
Más filtros

País/Región como asunto
Intervalo de año de publicación
1.
Salud Publica Mex ; 64(1): 100-104, 2022 Feb 25.
Artículo en Español | MEDLINE | ID: mdl-35438915

RESUMEN

In 2014, a partnership was established between the Univer-sity of California and Mexico, which subsequently catalyzed formation of collaborations between cancer researchers at University of California, San Francisco and in Mexico. Over the past two decades cancer burden has dramatically increased in Mexicans on both sides of the California - Mexico border. Together, we face a growing burden of cancer in the context of globalized economies, diverse migration patterns, and dynamic immigration policies. Our partnership aims to: (1) understand the life course impact of cancer risk factors and interactions with changing environments; (2) address cancer disparities within Mexico, in Mexican migrants to the United States, and in naturalized Mexican-Americans; and (3) identify effective cancer screening strategies and cancer control policies that are tailored to existing healthcare systems and social and cultural factors. Herein, we describe the principles of partner-ship and early successes and challenges of this collaboration.


Asunto(s)
Neoplasias , Migrantes , Atención a la Salud , Emigración e Inmigración , Humanos , Americanos Mexicanos , México/epidemiología , Neoplasias/epidemiología , Estados Unidos
2.
Salud Publica Mex ; 62(5): 504-510, 2020.
Artículo en Español | MEDLINE | ID: mdl-33027861

RESUMEN

OBJECTIVE: To describe the adult subsample for the analysis of biomarkers of chronic diseases, as well as the sample sizes (n) and representativity of the Encuesta Nacional de Salud y Nutrición (Ensanut) 2016. MATERIALS AND METHODS: An adult subsample with national representativity was calculated to obtain blood, serum and urine samples. The prevalence of variables of interest was compared for each subsample. RESULTS: The n for at least one serum biomarker and urine samples were 4 000 and 3 782, respectively. The n varied depending on the grouping of biomarkers and fasting time selection. No differences were observed in the distribution of variables between the whole sample, urine and blood biomarkers samples. CONCLUSIONS: The weighted subsamples of urine, serum and blood biomarkers are comparable to the weighted sample of adults in the survey. The data of the subsample will allow to monitor the distribution of chronic diseases in Mexico, including altered function of liver and kidney, and sodium intake.


OBJETIVO: Describir la submuestra de adultos para el análisis de biomarcadores de enfermedades crónicas, así como los tamaños de muestra (n) y la representatividad de las mismas en la Encuesta Nacional de Salud y Nutrición 2016. MATERIAL Y MÉTODOS: Se calculó una submuestra con representati-vidad nacional para la obtención de sangre, suero y orina en adultos. Se comparó la prevalencia de variables de interés para las submuestras. RESULTADOS: Las n obtenidas de suero y orina fueron de 4 000 y 3 782 adultos con al menos un valor en algún marcador bioquímico sérico y marcadores de orina, respectivamente. Esta n varió con el agrupamiento de marcadores y selección por horas de ayuno. No se observa-ron diferencias en la distribución de las variables de interés entre las muestras de hogar, sangre y orina. CONCLUSIONES: Los datos ponderados de las submuestras de marcadores en orina, suero y sangre son comparables con la muestra total de adultos de la encuesta. Los datos de las submuestras permiti-rán monitorear la distribución de enfermedades crónicas en México, incluidas las alteraciones en función hepática, renal, y consumo de sodio.


Asunto(s)
Biomarcadores , Enfermedad Crónica/epidemiología , Adulto , Humanos , México/epidemiología , Encuestas Nutricionales
3.
Global Health ; 14(1): 84, 2018 08 22.
Artículo en Inglés | MEDLINE | ID: mdl-30134925

RESUMEN

BACKGROUND: Type 2 Diabetes (T2D) is now a massive epidemic in both California and Mexico, with serious consequences for social and economic well-being. A large proportion of these populations share common ethnic backgrounds. Yet diverse environmental and social conditions across regions create unique opportunities to explore the ways that T2D risk, incidence, management and outcomes manifest. MAIN TEXT: An action-oriented research consortium headed up by the University of California and Universidad Nacional Autónoma de Mexico was constituted to set priorities for bi-national translational research, in an attempt to implement and evaluate clinical, public health and policy actions to decrease the burden of T2D for people of Mexican origin. In this paper, we describe the epidemiology of T2D in Mexico and California, review current efforts to combat the epidemic, highlight gaps in knowledge and identify urgent areas of opportunity for collaboration. The group has developed a common research agenda and funding has been obtained to evaluate biological samples from the 2016 Mexican Health Survey, collaborate in a telemedicine-based retinopathy project, implement interventions in food banks, promote a communications campaign, and design a large-scale diabetes prevention effectiveness trial. CONCLUSIONS: T2D has caused a state of emergency in Mexico and is a major health problem among Mexican populations on both sides of the border. Understanding the commonalities and differences between California and Mexico for those of Mexican origin with respect to T2D, when combined with a sharing of knowledge and advances, can produce a bi-national translational research agenda to inform relevant policy and practice. Amidst economic and political uncertainty and limited healthcare budgets, this collaboration can contribute to the development of scientific evidence to inform policies and interventions. This may provide a promising collaborative model that could be expanded to other health conditions and regions of the world.


Asunto(s)
Diabetes Mellitus Tipo 2/etnología , Diabetes Mellitus Tipo 2/prevención & control , Cooperación Internacional , Americanos Mexicanos/estadística & datos numéricos , Investigación Biomédica Traslacional/organización & administración , California/epidemiología , Encuestas Epidemiológicas , Humanos , Incidencia , México/epidemiología , Riesgo , Estados Unidos/epidemiología
4.
Salud Publica Mex ; 52(5): 432-46, 2010.
Artículo en Español | MEDLINE | ID: mdl-21031250

RESUMEN

OBJECTIVE: To develop an automated model for the operational regionalization needed in the planning of the health service networks proposed by the new Mexican health care model (Modelo Integrador de Servicios de Salud MIDAS). MATERIAL AND METHODS: Using available data for México during 2005 and 2007, a geospatial model was developed to estimate potential catchment areas around health facilities based on access travel time. The results were compared with an operational regionalization (ERO) study manually carried out in Oaxaca with 2005 data. RESULTS: The ERO assigned 48% of villages to health care centers further away than those assigned by the geospatial model, and 23% of these health centers referred patients to more distant hospitals. CONCLUSIONS: The model calculated by this study generated a more efficient regionalization than the ERO model, minimizing travel time to access health services. This model has been adopted by the General Department of Health Planning and Development of the Mexican Ministry of Health for the implementation of the Health Sector Infrastructure Master Plan.


Asunto(s)
Instituciones de Salud/provisión & distribución , Accesibilidad a los Servicios de Salud , Modelos Teóricos , Regionalización , Automatización , Áreas de Influencia de Salud , Geografía , Planificación de Instituciones de Salud , Hospitales Públicos/estadística & datos numéricos , Humanos , México , Planificación Social , Seguridad Social , Factores de Tiempo , Viaje
5.
Contemp Clin Trials ; 95: 106067, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32580032

RESUMEN

INTRODUCTION: Type 2 diabetes (T2D) is a global epidemic, and nations are struggling to implement effective healthcare strategies to reduce the burden. While efficacy studies demonstrate that metformin can reduce incident T2D by half among younger, obese adults with prediabetes, its real-world effectiveness are understudied, and its use for T2D prevention in primary care is low. We describe the design of a pragmatic trial to evaluate the incremental effectiveness of metformin, as an adjunct to a simple lifestyle counseling. METHODS: The "Prevención de la Diabetes con Ejercicio, Nutrición y Tratamiento" [Diabetes Prevention with Exercise, Nutrition and Treatment; PRuDENTE, (Spanish acronym)] is a cluster-randomized trial in Mexico City's public primary healthcare system. The study randomly assigns 51 clinics to deliver one of two interventions for 36 months: 1) lifestyle only; 2) lifestyle plus metformin, to 3060 patients ages 30-65 with impaired fasting glucose and obesity. The primary endpoint is incident T2D (fasting glucose ≥126 mg/dL, or HbA1c ≥6.5%). We will also measure a range of implementation-related process outcomes at the clinic-, clinician- and patient-levels to inform interpretations of effectiveness and enable efforts to refine, adapt, adopt and disseminate the model. We will also estimate the cost-effectiveness of metformin as an adjunct to lifestyle counseling in Mexico. DISCUSSION: Findings from this pragmatic trial will generate new translational knowledge in Mexico and beyond, both with respect to metformin's real-world effectiveness among an 'at-risk' population, and uncovering facilitators and barriers to the reach, adoption and implementation of metformin preventive therapy in public primary care settings. TRIAL REGISTRATION: This trial is registered at Clinicaltrials.gov (NCT03194009).


Asunto(s)
Diabetes Mellitus Tipo 2 , Metformina , Estado Prediabético , Adulto , Anciano , Análisis Costo-Beneficio , Diabetes Mellitus Tipo 2/epidemiología , Diabetes Mellitus Tipo 2/prevención & control , Humanos , Metformina/uso terapéutico , México/epidemiología , Persona de Mediana Edad , Estado Prediabético/tratamiento farmacológico , Estado Prediabético/epidemiología
6.
Salud pública Méx ; 64(1): 100-104, ene.-feb. 2022. tab
Artículo en Inglés | LILACS-Express | LILACS | ID: biblio-1432354

RESUMEN

Abstract: In 2014, a partnership was established between the University of California and Mexico, which subsequently catalyzed formation of collaborations between cancer researchers at University of California, San Francisco and in Mexico. Over the past two decades cancer burden has dramatically increased in Mexicans on both sides of the California - Mexico border. Together, we face a growing burden of cancer in the context of globalized economies, diverse migration patterns, and dynamic immigration policies. Our partnership aims to: 1) understand the life course impact of cancer risk factors and interactions with changing environments; 2) address cancer disparities within Mexico, in Mexican migrants to the United States, and in naturalized Mexican-Americans; and 3) identify effective cancer screening strategies and cancer control policies that are tailored to existing healthcare systems and social and cultural factors. Herein, we describe the principles of partnership and early successes and challenges of this collaboration.


Resumen: En 2014, se estableció un convenio de colaboración colaboración entre la Universidad de California y México, que posteriormente catalizó colaboraciones específicas entre investigadores en cáncer en la Universidad de California, San Francisco y en México. En las últimas dos décadas, la carga del cáncer ha aumentado drásticamente en mexicanos de ambos lados de la frontera entre California y México. Juntos, enfrentamos una carga creciente de cáncer en un contexto de economías globalizadas y diversos patrones y políticas de migración dinámicas. Nuestra colaboración tiene como objetivo: 1) entender el impacto a lo largo de la vida de factores de riesgo de cáncer y sus interacciones en un entorno cambiante; 2) abordar disparidades del cáncer dentro de México, en os migrantes mexicanos a los Estados Unidos y en los mexicoamericanos naturalizados; y 3) identificar estrategias efectivas de detección del cáncer y políticas de control del cáncer que se adapten a sistemas de salud existentes y a factores sociales y culturales. Aquí describimos los principios de esta colaboración y los primeros éxitos y retos de la misma.

7.
Salud pública Méx ; 62(5): 504-510, sep.-oct. 2020. tab
Artículo en Español | LILACS | ID: biblio-1390313

RESUMEN

Resumen Objetivo: Describir la submuestra de adultos para el análisis de biomarcadores de enfermedades crónicas, así como los tamaños de muestra (n) y la representatividad de las mismas en la Encuesta Nacional de Salud y Nutrición 2016. Material y métodos: Se calculó una submuestra con representatividad nacional para la obtención de sangre, suero y orina en adultos. Se comparó la prevalencia de variables de interés para las submuestras. Resultados: Las n obtenidas de suero y orina fueron de 4 000 y 3 782 adultos con al menos un valor en algún marcador bioquímico sérico y marcadores de orina, respectivamente. Esta n varió con el agrupamiento de marcadores y selección por horas de ayuno. No se observaron diferencias en la distribución de las variables de interés entre las muestras de hogar, sangre y orina. Conclusión: Los datos ponderados de las submuestras de marcadores en orina, suero y sangre son comparables con la muestra total de adultos de la encuesta. Los datos de las submuestras permitirán monitorear la distribución de enfermedades crónicas en México, incluidas las alteraciones en función hepática, renal, y consumo de sodio.


Abstract Objective: To describe the adult subsample for the analysis of biomarkers of chronic diseases, as well as the sample sizes (n) and representativity of the Encuesta Nacional de Salud y Nutrición (Ensanut) 2016. Materials and methods: An adult subsample with national representativity was calculated to obtain blood, serum and urine samples. The prevalence of variables of interest was compared for each subsample. Results: The n for at least one serum biomarker and urine samples were 4 000 and 3 782, respectively. The n varied depending on the grouping of biomarkers and fasting time selection. No differences were observed in the distribution of variables between the whole sample, urine and blood biomarkers samples. Conclusion: The weighted subsamples of urine, serum and blood biomarkers are comparable to the weighted sample of adults in the survey. The data of the subsample will allow to monitor the distribution of chronic diseases in Mexico, including altered function of liver and kidney, and sodium intake.


Asunto(s)
Adulto , Humanos , Biomarcadores , Enfermedad Crónica/epidemiología , Encuestas Nutricionales , México/epidemiología
8.
J Acquir Immune Defic Syndr ; 69(3): e100-8, 2015 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-25886921

RESUMEN

INTRODUCTION: Universal coverage of highly active antiretroviral therapy (HAART) for HIV/AIDS in Mexico was achieved in a staggered fashion. First, HAART was made available in 1997 for employees in the formal sector and subsequently, in 2003, for informal sector workers and the unemployed population. We evaluated the impact of this free universal HAART program on HIV/AIDS mortality in the Mexican population aged 15 years or older. METHODS: Time-series cross-sectional data analysis of standardized HIV/AIDS mortality rates (1990-2011) using marginal linear models with inflection points at 1994, 1997, and 2003. RESULTS: Men employed in the formal sector experienced the greatest effect of access to HAART, with a 32% reduction in mortality from 1997 to 2011 (P < 0.01). For men in this sector, mortality increased from 1990 to 2003, then stabilizing at 7 deaths per 100,000. For women in the informal sector, mortality increased from 1990 to 2011. We found large between-state variability: mortality decreased by 59% in Mexico City while it increased by 245% in Tabasco during the study period. Six of 32 states achieved statistically significant reductions in mortality while 5 states continued to experience increasing mortality rates despite universal HAART. CONCLUSIONS: Access to universal HAART has had relative success in Mexico. The heterogeneity of HIV/AIDS mortality by employment status, gender, and state of residence highlight urgent needs to improve health equity with pro-poor and gender-responsive programs and a call for country-specific operational research in HIV/AIDS prevention and treatment. Our results may apply to other countries seeking to implement universal access to antiretroviral therapy.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/tratamiento farmacológico , Síndrome de Inmunodeficiencia Adquirida/mortalidad , Fármacos Anti-VIH/uso terapéutico , Terapia Antirretroviral Altamente Activa , Síndrome de Inmunodeficiencia Adquirida/epidemiología , Adulto , Fármacos Anti-VIH/administración & dosificación , Estudios Transversales , Femenino , Accesibilidad a los Servicios de Salud , Humanos , Modelos Lineales , Masculino , México/epidemiología , Programas Nacionales de Salud , Factores Socioeconómicos
9.
Salud Publica Mex ; 44(6): 519-32, 2002.
Artículo en Español | MEDLINE | ID: mdl-20383454

RESUMEN

OBJECTIVE: To describe the geographical coverage of the Mexican Healthcare System (MHS) services and to assess the utilization of its General Hospitals. MATERIAL AND METHODS: A Geographic Information System (GIS) was used to include sociodemographic data by locality, the geographical location of all MHS healthcare services, and data on hospital discharge records. A maximum likelihood estimation model was developed to assess the utilization levels of 217 MHS General Hospitals. The model included data on human resources, additional infrastructure, and the population within a 25 km radius. RESULTS: In 1998, 10,806 localities with 72 million inhabitants had at least one public healthcare unit, and 97.2% of the population lived within 50 km of a healthcare unit; however, over 18 million people lived in rural localities without a healthcare unit. The mean annual hospital occupation rate was 48.5 +/- 28.5 per 100 bed/years, with high variability within and between states. Hospital occupation was significantly associated with the number of physicians in the unit, and in the Mexican Institute of Social Security units utilization was associated with additional health infrastructure, and with the population's poverty index. CONCLUSIONS: GIS analysis allows improved estimation of the coverage and utilization of MHS hospitals.


Asunto(s)
Atención a la Salud , Hospitales Generales/estadística & datos numéricos , Cobertura del Seguro , Hospitales Generales/provisión & distribución , Humanos , México
10.
Salud pública Méx ; 52(5): 432-446, sept.-oct. 2010. ilus, graf, mapas, tab
Artículo en Español | LILACS | ID: lil-562207

RESUMEN

Objetivo. Desarrollar un modelo automatizado de regionalización operativa para la planeación de las redes de servicios de salud propuestas en el Modelo Integrador de Atención a la Salud (MIDAS). Material y métodos. Con información disponible para México en 2005 y 2007 se realizó un modelo geoespacial para estimar el área potencial de influencia alrededor de cada unidad de atención médica, con base en el menor tiempo de viaje. Los resultados se compararon con un Estudio de Regionalización Operativa (ERO) para Oaxaca llevado a cabo en 2005. Resultados. Comparado con el modelo geoespacial, el ERO asignó 48 por ciento de las localidades a centros de salud más lejanos y 23 por ciento de los centros de salud a hospitales más lejanos. Conclusiones. El modelo calculado en este estudio generó una regionalización más eficiente que el ERO de Oaxaca, minimizando el tiempo de viaje para el acceso a los servicios de salud. Este modelo ha sido adoptado por la Dirección General de Planeación y Desarrollo en Salud para la instrumentación del Plan Maestro Sectorial de Recursos para la Atención de la Salud.


Objective. To develop an automated model for the operational regionalization needed in the planning of the health service networks proposed by the new Mexican health care model (Modelo Integrador de Servicios de Salud MIDAS). Material and Methods. Using available data for México during 2005 and 2007, a geospatial model was developed to estimate potential catchment areas around health facilities based on access travel time. The results were compared with an operational regionalization (ERO) study manually carried out in Oaxaca with 2005 data. Results. The ERO assigned 48 percent of villages to health care centers further away than those assigned by the geospatial model, and 23 percent of these health centers referred patients to more distant hospitals. Conclusions. The model calculated by this study generated a more efficient regionalization than the ERO model, minimizing travel time to access health services. This model has been adopted by the General Department of Health Planning and Development of the Mexican Ministry of Health for the implementation of the Health Sector Infrastructure Master Plan.


Asunto(s)
Humanos , Instituciones de Salud/provisión & distribución , Accesibilidad a los Servicios de Salud , Modelos Teóricos , Regionalización , Automatización , Áreas de Influencia de Salud , Geografía , Planificación de Instituciones de Salud , Hospitales Públicos , México , Planificación Social , Seguridad Social , Factores de Tiempo , Viaje
11.
Salud Publica Mex ; 44 Suppl 1: S161-9, 2002.
Artículo en Español | MEDLINE | ID: mdl-12061341

RESUMEN

Smoking is presently one of the most important public health problems worldwide. Even though smoking is a preventable cause of morbidity and mortality, it still contributes importantly to the burden of disease. In Mexico, contrary to what is happening in other parts of the world, the smoking epidemic is in an early phase, as evidenced by the low number of lung cancer cases or deaths, and by the minimal public health efforts to control tobacco consumption. One of the most important advances is its recognition as a priority public health problem by public health workers and society in general. Effective interventions to reduce tobacco consumption have been launched to render the country free of tobacco. These public health interventions are being countered by the tobacco industry and the market forces that strive to preserve smoking as a life style of the population. The present work reviews the production means of the Mexican tobacco industry, particularly those of cigarettes, the market structure, and the product expansion in the Mexican population. This information should be useful to frame effective preventive measures, in the short and long term, to control this epidemic.


Asunto(s)
Industria del Tabaco , México , Industria del Tabaco/estadística & datos numéricos
12.
Salud Publica Mex ; 45 Suppl 4: S466-76, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14746041

RESUMEN

OBJECTIVE: To compare the prevalence of undernutrition and anemia in indigenous and non-indigenous children < 5 years of age at the national level, by region and by urban and rural areas, and to evaluate the degree to which the socioeconomic condition of the family predicts the differences. MATERIAL AND METHODS: A national probabilistic survey was conducted in Mexico in 1999. Indigenous families were identified as those in which at least one woman 12-49 years of age in the household spoke a native language. The prevalence of undernutrition (stunting, wasting and underweight) and anemia was compared between indigenous and non-indigenous children. Probability ratios (PR) were used to compare prevalences in indigenous and non-indigenous children adjusting for socioeconomic status (SES) of the family and for other covariates. RESULTS: The prevalences of stunting and underweight were greater in indigenous than in non-indigenous children. At the national level and in urban areas the prevalences were three times greater and in rural areas approximately 2 times greater (p < 0.05). No differences were found in the prevalence of wasting (p > 0.05). The prevalence of anemia in indigenous children was one third greater than in non-indigenous children at the national level (p < 0.05) and was between 30 and 60% greater in urban areas and in the regions studied (p < 0.05) but was not statistically significant (p > 0.05) in rural areas. These differences were reduced to about half when adjusting for SES but remained significantly higher in indigenous children (p < 0.05). CONCLUSIONS: Indigenous children have higher probabilities of stunting and underweight than non-indigenous children. The differences are larger in urban areas and in higher socioeconomic geographic regions and are explained mostly by socioeconomic factors. The overall difference in the probability of anemia is small, is higher only in urban relative to rural areas, and is explained to a lesser degree by socioeconomic factors. Policy and programs should be designed and implemented to reduce the dramatic differences in nutritional status between indigenous and non-indigenous children in Mexico. The English version of this paper is available too at: http://www.insp.mx/salud/index.html.


Asunto(s)
Indígenas Norteamericanos , Estado Nutricional , Adolescente , Adulto , Anemia/epidemiología , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Desnutrición/epidemiología , México/epidemiología , Persona de Mediana Edad , Prevalencia , Factores Socioeconómicos
13.
Salud Publica Mex ; 45 Suppl 4: S558-64, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14746050

RESUMEN

OBJECTIVE: To describe the methods and analyses of the 1999 National Nutrition Survey (NNS-99). MATERIAL AND METHODS: The 1999 National Nutrition Survey (NNS-99) is a probabilistic survey with nationwide representativity. The NNS-99 included four regions and urban and rural areas of Mexico. The last sampling units were households, selected through stratified cluster sampling. The study population consisted of children under five years of age, school-age children (6-11 years), and women of childbearing age (12-49 years). Data were collected on anthropometric measurements, hemoglobin levels, morbidity and its determinants, and socioeconomic and demographic characteristics. In addition, data on diet and micronutrients intakes (iron, zinc, vitamin A, folic acid, vitamin C, and iodine) were obtained in a sub-sample of subjects. RESULTS: The response rate for the NNS-99 was 82.3%; the non-response rate was 5.9% and the remaining did not participate due to uninhabited houses. CONCLUSIONS: This survey updates the information on nutritional status in Mexico and should serve as the basis for food and nutrition policy-making and priority program design. The English version of this paper is available too at: http://www.insp.mx/salud/index.html.


Asunto(s)
Encuestas Nutricionales , Adolescente , Adulto , Niño , Preescolar , Recolección de Datos/métodos , Femenino , Humanos , Lactante , Masculino , México , Persona de Mediana Edad
14.
Salud Publica Mex ; 45 Suppl 4: S565-75, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14746051

RESUMEN

OBJECTIVE: This article presents and overview of the main results and conclusions from the Mexican National Nutrition Survey 1999 (NNS-1999) and the principal nutrition policy implications of the findings. MATERIAL AND METHODS: The NNS-1999 was conducted on a national probabilistic sample of almost 18,000 households, representative of the national, regional, as well as urban and rural levels in Mexico. Subjects included were children < 12 years and women 12-49 years. Anthropometry, blood specimens, diet and socioeconomic information of the family were collected. RESULTS: The principal public nutrition problems are stunting in children < 5 years of age; anemia, iron and zinc deficiency, and low serum vitamin C concentrations at all ages; and vitamin A deficiency in children. Undernutrition (stunting and micronutrient deficiencies) was generally more prevalent in the lower socioeconomic groups, in rural areas, in the south and in Indigenous population. Overweight and obesity are serious public health problems in women and are already a concern in school-age children. CONCLUSIONS: A number of programs aimed at preventing undernutrition are currently in progress; several of them were designed or modified as a result of the NNS-1999 findings. Most of them have an evaluation component that will inform adjustments or modifications of their design and implementation. However, little is being done for the prevention and control of overweight and obesity and there is limited experience on effective interventions. The design and evaluation of prevention strategies for controlling obesity in the population, based on existing evidence, is urgently needed and success stories should be brought to scale quickly to maximize impact. The English version of this paper is available too at: http://www.insp.mx/salud/index.html.


Asunto(s)
Política Nutricional , Encuestas Nutricionales , Adolescente , Adulto , Anemia/epidemiología , Niño , Preescolar , Insuficiencia de Crecimiento/epidemiología , Femenino , Humanos , Lactante , Masculino , México/epidemiología , Micronutrientes/deficiencia , Persona de Mediana Edad , Prevalencia
15.
Vaccine ; 20(21-22): 2790-5, 2002 Jun 21.
Artículo en Inglés | MEDLINE | ID: mdl-12034106

RESUMEN

The reactogenicity and immunogenicity of combined measles and rubella (MR) booster vaccination, via aerosol and subcutaneous routes, was assessed in 562 healthy children. Rates of rubella seroconversion and geometric mean titers (GMT) were similar for both routes. Rates of measles PN seroconversion, GMT and measles ELISA post-vaccination seropositivity and seroconversion rate were each higher for aerosol vaccine (54%, 3928 IU/l, 99.6 and 98.8%), than for subcutaneous vaccine (7%, 866 IU/l, 92.2 and 82.4%) (P<0.01). Reactogenicity was higher for subcutaneous vaccine (P<0.05). This study demonstrates that aerosol vaccine was more immunogenic for measles antibodies, and equally immunogenic for rubella antibodies. Aerosol vaccine was less reactogenic.


Asunto(s)
Inmunización Secundaria , Vacuna Antisarampión/administración & dosificación , Sarampión/inmunología , Vacuna contra la Rubéola/inmunología , Aerosoles , Anticuerpos Antivirales/sangre , Formación de Anticuerpos , Niño , Preescolar , Femenino , Humanos , Inyecciones Subcutáneas , Vacuna Antisarampión/efectos adversos , Vacuna Antisarampión/inmunología , Virus del Sarampión/inmunología , Rubéola (Sarampión Alemán)/inmunología , Rubéola (Sarampión Alemán)/prevención & control , Vacuna contra la Rubéola/administración & dosificación , Vacuna contra la Rubéola/efectos adversos
16.
Salud Publica Mex ; 45 Suppl 4: S551-7, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14746049

RESUMEN

OBJECTIVE: The objective of the study was to measure the prevalence of overweight and obesity in Mexican school-age children (5-11 years) in the National Nutrition Survey 1999 (NNS-1999). MATERIAL AND METHODS: Overweight and obesity (defined as an excess of adipose tissue in the body) were evaluated through the Body Mass Index (BMI) in 10,901 children, using the standard proposed by the International Obesity Task Force. Sociodemographic variables were obtained using a questionnaire administered to the children's mothers. RESULTS: The national prevalence of overweight and obesity was reported to be 19.5%. The highest prevalence figures were found in Mexico City (26.6%) and the North region (25.6%). When adjusting by region, rural or urban area, sex, maternal schooling, socioeconomic status, indigenous ethnicity and age, the highest prevalences of overweight and obesity were found among girls. The risks of overweight and obesity were positively associated with maternal schooling, children's age and socioeconomic status. CONCLUSIONS: Overweight and obesity are prevalent health problems in Mexican school-age children, particularly among girls, and positively associated with socioeconomic status, age, and maternal schooling. This is a major public health problem requiring preventive interventions to avoid future health consequences. The English version of this paper is available too at: http://www.insp.mx/salud/index.html.


Asunto(s)
Encuestas Nutricionales , Obesidad/epidemiología , Niño , Preescolar , Estudios Transversales , Femenino , Humanos , Masculino , México/epidemiología , Análisis Multivariante , Prevalencia , Encuestas y Cuestionarios
17.
Salud Publica Mex ; 44 Suppl 1: S125-35, 2002.
Artículo en Español | MEDLINE | ID: mdl-12055735

RESUMEN

Tobacco consumption is one of the most important public health challenges faced in the Americas. This is not only due to the great number of deaths attributable to smoking, many of which are premature, but also to the high economic and social costs of medical care and the burden of disease and disability imposed by tobacco consumption on health systems and on the population. In the regional epidemiologic situation. South American countries are characterized by the highest consumption rates, followed by the Andean region and Mexico; Central American and Caribbean countries have the lowest smoking prevalences. Only the United States and Canada have been able to hold back the smoking epidemic; the rest of the hemisphere shows stable or increasing smoking rates. In the region, age of smoking initiation has decreased and the number of women who smoke has increased. This article reviews the current tobacco control measures in Latin American legislations and analyzes selected regional characteristics such as the structure of young populations, control measures that are weak or scarce, and the world production of tobacco. There is a compelling need to establish economic, population-based, and legislative procedures leading to a gradual reduction of the current tobacco consumption rates. This paper advances a comprehensive action plan against tobacco consumption.


Asunto(s)
Desarrollo de Programa , Prevención del Hábito de Fumar , Fumar/epidemiología , Adolescente , Adulto , Américas/epidemiología , Niño , Humanos
18.
Bull World Health Organ ; 80(10): 806-12, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12471401

RESUMEN

OBJECTIVE: To compare antibody responses and side-effects of aerosolized and injected measles vaccines after revaccination of children enrolling in elementary schools. METHODS: Vaccines for measles (Edmonston-Zagreb) or measles-rubella (Edmonston-Zagreb with RA27/3) were given by aerosol or injection to four groups of children. An additional group received Schwarz measles vaccine by injection. These five groups received vaccines in usual standard titre doses. A sixth group received only 1000 plaque-forming units of Edmonston-Zagreb vaccine by aerosol. The groups were randomized by school. Concentrations of neutralizing antibodies were determined in blood specimens taken at baseline and four months after vaccination from randomized subgroups (n = 28-31) of children in each group. FINDINGS: After baseline antibody titres were controlled for, the frequencies of fourfold or greater increases in neutralizing antibodies did not differ significantly between the three groups that received vaccine by aerosol (range 52%-64%), but they were significantly higher than those for the three groups that received injected vaccine (range 4%-23%). Mean increases in titres and post-vaccination geometric mean titres paralleled these findings. Fewer side-effects were noted after aerosol than injection administration of vaccine. CONCLUSION: Immunogenicity of measles vaccine when administered by aerosol is superior to that when the vaccine is given by injection. This advantage persists with aerosolized doses less than or equal to one-fifth of usual injected doses. The efficacy and cost-effectiveness of measles vaccination by aerosol should be further evaluated in mass campaigns.


Asunto(s)
Anticuerpos Antivirales/sangre , Inmunización Secundaria , Vacuna Antisarampión/administración & dosificación , Vacuna contra la Rubéola/administración & dosificación , Vacunas Combinadas/administración & dosificación , Aerosoles , Anticuerpos Antivirales/biosíntesis , Niño , Ensayo de Inmunoadsorción Enzimática , Humanos , Inyecciones Intramusculares , Vacuna Antisarampión/efectos adversos , Vacuna Antisarampión/inmunología , México , Nebulizadores y Vaporizadores , Pruebas de Neutralización , Vacuna contra la Rubéola/efectos adversos , Vacuna contra la Rubéola/inmunología , Vacunas Combinadas/efectos adversos , Vacunas Combinadas/inmunología
19.
Vaccine ; 22(9-10): 1214-20, 2004 Mar 12.
Artículo en Inglés | MEDLINE | ID: mdl-15003650

RESUMEN

The purpose of the present study was to compare serum and mucosal immune responses following either aerosol (Aer) or subcutaneous (SQ) measles immunization of Mexican school children. A cohort of 49 children from 6 to 7 years of age received either Aer ( n = 22) or SQ ( n = 27) Edmonston-Zagreb (EZ) measles vaccine. Serum and nasal secretions were collected prior to (Pre), 1 and 3 months (mos) intervals and analyzed for immunoglobulin (Ig) concentrations and measles specific Ig isotype-associated antibody by enzyme immunoassay (EIA). Serum and nasal IgG and IgA antibody responses were stimulated following immunization with live, attenuated EZ measles vaccine administered either by SQ or Aer routes but these responses were significantly greater by the Aer compared to the SQ route. These studies also suggest that the level of antibody in these secretions may serve as an important marker of immunity to measles and lend further support for aerosol immunization as an effective alternative vaccine delivery strategy for measles eradication.


Asunto(s)
Inmunidad Mucosa/inmunología , Vacuna Antisarampión/inmunología , Administración Intranasal , Aerosoles , Niño , Femenino , Humanos , Inmunización Secundaria , Inmunoglobulina A/análisis , Inmunoglobulina A/biosíntesis , Inmunoglobulina G/análisis , Inmunoglobulina G/biosíntesis , Inyecciones Subcutáneas , Masculino , Vacuna Antisarampión/efectos adversos , México
20.
Salud pública Méx ; 44(supl.1): s161-s169, 2002. ilus, tab
Artículo en Español | LILACS | ID: lil-464243

RESUMEN

El tabaquismo es uno de los problemas de salud pública más importantes del siglo pasado y del presente. Lo paradójico de la práctica de la salud pública es que el tabaquismo es un evento totalmente prevenible que ha estado presente en el desarrollo de la sociedad, contribuyendo de manera importante en la morbilidad y mortalidad, aun a costa de la evolución que ha tenido la salud pública mundial. En el caso de México, al contrario que en otras partes del mundo, la ola epidémica del tabaquismo se encuentra en su primera fase, expresada en la morbilidad y mortalidad asociadas, como el cáncer pulmonar, así como por las mínimas actividades preventivas instrumentadas; pero un buen avance ha sido el reconocimiento que como problema prioritario de salud se ha dado por los trabajadores de la salud pública y la sociedad. Se han iniciado las acciones de intervención tendientes a disminuir el consumo de tabaco entre la población y, con ello, dejar sembrado el camino de la prevención para futuras generaciones libres de tabaco. Frente a estas acciones de intervención se encuentran la industria tabacalera y los mecanismos de reproducción del mercado que opera para mantener el consumo de tabaco como un hábito de vida poblacional. El presente trabajo revisa los mecanismos de producción del tabaco, en especial de los cigarrillos, así como la comercialización, estructura del mercado y penetración del producto en la población mexicana, para contribuir con elementos de comprensión de la epidemia mexicana de tabaquismo para la implantación de medidas preventivas exitosas, presentes y futuras, para el control de la epidemia.


Abstract Smoking in presently one of the most important public health problems worldwide. Even though smoking is a preventable cause of morbidity and mortality, it still contributes importantly to the burden of disease. In Mexico, contrary to what is happening in other parts of the world, the smoking epidemic is in an early phase, as evidenced by the low number of lung cancer cases or deaths, and by the minimal public health efforts to control tobacco consumption. One of the most important advances is its recognition as a priority public health problem by public health workers and society in general. Effective interventions to reduce tobacco consumption have been launched to render the country free of tobacco. These public health interventions are being countered by the tobacco industry and the market forces that strive to preserve smoking as a life style of the population. The present work reviews the production means of the Mexican tobacco industry, particularly those of cigarettes, the market structure, and the product expansion in the Mexican population. This information should be useful to frame effective preventive measures, in the short and long term, to control this epidemic.


Asunto(s)
Industria del Tabaco , México , Industria del Tabaco/estadística & datos numéricos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA